Li Yun-Yi, Cen Haohua, Gong Bei-Ni, Mai Siqi, Wang Qi-Long, Mou Sisi, Li Yingqiu
Guangdong Province Key Laboratory of Pharmaceutical Functional Genes, MOE Key Laboratory of Gene Function and Regulation, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, China.
Front Cell Dev Biol. 2022 Feb 2;9:789348. doi: 10.3389/fcell.2021.789348. eCollection 2021.
Small ubiquitin-like modifier (SUMO) modification plays an important regulatory role in T cell receptor (TCR) signaling transduction. SUMO-specific proteases (SENPs) have dual-enzyme activities; they can both process SUMO precursors as endopeptidases and participate in SUMO deconjugation as isopeptidases. It remains unclear how the SUMO system, especially SENP1, is regulated by TCR signaling. Here, we show that Lck phosphorylates tyrosine 270 (Y270) of SENP1 upon TCR stimulation, indicating that SENP1 is a substrate of Lck. endopeptidase activity analysis showed that mutating SENP1 Y270 to either phenylalanine (F) to mimic the phosphorylation-defective state or to glutamate (E) to mimic the negative charge of tyrosine phosphorylation in the enzyme microenvironment did not change its endopeptidase activity towards pre-SUMO1. However, SENP1 Y270E but not Y270F mutation exhibited decreased endopeptidase activity towards pre-SUMO3. Through isopeptidase activity analysis by rescue expression of SENP1 and its Y270 mutants in a SENP1 CRISPR knockout T cell line, we found that SENP1 Y270F downregulated its isopeptidase activity towards both SUMO1 and SUMO2/3 conjugation by reducing SENP1 binding with sumoylated targets. While overexpression of SENP1 inhibited TCR-induced IL-2 production, overexpression of SENP1 Y270F enhanced it instead. In summary, TCR-induced Y270 phosphorylation of SENP1 may promote its isopeptidase activity and specifically decrease its endopeptidase activity against pre-SUMO3, which finely tunes activation of T cells.
小泛素样修饰物(SUMO)修饰在T细胞受体(TCR)信号转导中发挥重要的调节作用。SUMO特异性蛋白酶(SENPs)具有双酶活性;它们既可以作为内肽酶加工SUMO前体,又可以作为异肽酶参与SUMO去共轭化。目前尚不清楚SUMO系统,尤其是SENP1,是如何被TCR信号调节的。在此,我们表明,在TCR刺激后,Lck使SENP1的酪氨酸270(Y270)磷酸化,这表明SENP1是Lck的底物。内肽酶活性分析表明,将SENP1 Y270突变为苯丙氨酸(F)以模拟磷酸化缺陷状态,或突变为谷氨酸(E)以模拟酶微环境中酪氨酸磷酸化的负电荷,均不会改变其对前体SUMO1的内肽酶活性。然而,SENP1 Y270E突变体而非Y270F突变体对前体SUMO3的内肽酶活性降低。通过在SENP1 CRISPR敲除T细胞系中拯救表达SENP1及其Y270突变体进行异肽酶活性分析,我们发现SENP1 Y270F通过减少SENP1与SUMO化靶标的结合,下调了其对SUMO1和SUMO2/3共轭的异肽酶活性。虽然SENP1的过表达抑制了TCR诱导的白细胞介素-2(IL-2)产生,但SENP1 Y270F的过表达反而增强了IL-2的产生。总之,TCR诱导的SENP1 Y270磷酸化可能促进其异肽酶活性,并特异性降低其对前体SUMO3的内肽酶活性,从而精细调节T细胞的激活。